Kassler-Taub Kenneth B. has filed 18 insider transactions across 1 company since February 2023.
Most recent transaction: a option exercise of 7087 shares of LEXICON PHARMACEUTICALS, INC. ($LXRX) on February 28, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Common Stock | 7087 | $0.00 | 126,712.0000 | 0 | 5.92% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Common Stock | 27556 | $0.00 | 154,268.0000 | 0 | 21.75% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Common Stock | 32757 | $0.00 | 187,025.0000 | 0 | 21.23% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | F | Common Stock | 24353 | $2.62 | 162,672.0000 | 0 | 13.02% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Restricted Stock Units | 7087 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Restricted Stock Units | 27556 | $0.00 | 27,557.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Restricted Stock Units | 32757 | $0.00 | 65,513.0000 | 0 | 33.33% | 0.00% |
| Feb. 8, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | A | Restricted Stock Units | 203810 | $0.00 | 203,810.0000 | 0 | 9999.99% | 0.00% |
| Feb. 8, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | A | Stock Option (Right to Buy) | 203810 | $0.00 | 203,810.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Common Stock | 18243 | $0.00 | 104,100.0000 | 0 | 21.25% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Common Stock | 7086 | $0.00 | 111,186.0000 | 0 | 6.81% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Common Stock | 27557 | $0.00 | 138,743.0000 | 0 | 24.78% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | F | Common Stock | 19118 | $2.17 | 119,625.0000 | 0 | 13.78% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Restricted Stock Units | 18243 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Restricted Stock Units | 7086 | $0.00 | 7,087.0000 | 0 | 50.00% | 0.00% |
| Feb. 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | M | Restricted Stock Units | 27557 | $0.00 | 55,113.0000 | 0 | 33.33% | 0.00% |
| Feb. 9, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | A | Restricted Stock Units | 98270 | $0.00 | 98,270.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | Kassler-Taub Kenneth B. | SVP, Regulatory & QA | A | Stock Option (Right to Buy) | 294810 | $0.00 | 294,810.0000 | 0 | 9999.99% | 0.00% |